The production by filamentous fungi of therapeutic glycoproteins intended for use in mammals is held back by the inherent difference in protein N-glycosylation and by the inability of the fungal cell to modify proteins with mammalian glycosylation structures. Here, we report protein N-glycan engineering in two Aspergillus species. We functionally expressed in the fungal hosts heterologous chimeric fusion proteins containing different localization peptides and catalytic domains. This strategy allowed the isolation of a strain with a functional ␣-1,2-mannosidase producing increased amounts of N-glycans of the Man 5 GlcNAc 2 type. This strain was further engineered by the introduction of a functional GlcNAc transferase I construct yielding GlcNAcMan 5 GlcNac 2 N-glycans. Additionally, we deleted algC genes coding for an enzyme involved in an early step of the fungal glycosylation pathway yielding Man 3 GlcNAc 2 N-glycans. This modification of fungal glycosylation is a step toward the ability to produce humanized complex N-glycans on therapeutic proteins in filamentous fungi.
Filamentous fungi belonging to the Aspergillus group are well-established production hosts for extracellular enzymes of industrial importance, such as amylases, glucoamylases, pectinases, phytases, cellulases, and ligninases. (37) . Glucoamylase (1,4-␤-D-glucan glucohydrolase; EC 3.2.1.3) is one of the most prominent thermostable industrial enzymes (18) and is mainly produced by Aspergillus niger fermentation. Typical fermentation yields by A. niger are up to 25 g/liter of glucoamylase (3) .
In addition to homologous protein production, Aspergillus nidulans, A. niger, and Aspergillus oryzae have offered an attractive alternative to Escherichia coli and yeasts, such as Saccharomyces cerevisiae, Kluyveromyces lactis, or Pichia pastoris, for the expression of recombinant, heterologous proteins, and there have been a number of attempts to program filamentous fungi for the production of such heterologous proteins (13, 14, 20, 27, 29) .
Whereas posttranslational modifications of secreted heterologous proteins have been shown to influence protein stability, yield, and function, the production by filamentous fungi of therapeutic glycoproteins intended for use in mammals has been hampered by the inherent difference in protein N-glycosylation and by the inability of the fungal cell to modify proteins with mammalian glycosylation structures. While both fungi and mammals attach a specific oligosaccharide to asparagines in the sequence Asn-X-Ser/Thr/Cys (where X represents any amino acid except proline), the subsequent processing of the transferred glycan differs significantly between mammalian and fungal cells (47) . The assembly of a lipidlinked oligosaccharide composed of three gluocose (Glc 3 ), nine mannose (Man 9 ), and two N-acetylglucosamine (GlcNAc 2 ) residues (referred to as Glc 3 Man 9 GlcNAc 2 ), followed by transfer to the nascent protein and the removal of three glucose residues and one mannose sugar to yield Man 8 GlcNAc 2 , is conserved between eukaryotes. The biosynthetic glycosylation pathways diverge between fungi and mammals once a glycoprotein leaves the endoplasmic reticulum (ER) and is shuttled through the Golgi apparatus. Yeasts and other fungi typically produce high-mannose-type N-glycans by adding up to 100 mannose sugars, including beta-linked mannoses and mannosylphosphates, whereas the formation of mammalian glycans generally involves the removal of mannose, followed by the addition of N-acetylglucosamine, galactose, fucose, and sialic acid (8, 9, 25, 31) . Recently, glycoengineering in the yeast P. pastoris and the expression of therapeutic glycoproteins with complex "humanized" N-glycosylation structures have shown significant progress (4, 6, 10, 11, 15, 16, 26, 47) . Far less progress has been made in glycoengineering of fungal production hosts, such as Aspergillus or Trichoderma species, although the N-glycan structures of several secreted glycoproteins have been elucidated. (1, 2, 17, 24, 28, 29, 34, (39) (40) (41) 48) and attempts were made to modify fungal glycosylation structures by the insertion of glycan structuremodifying enzymes (17, 29, 32) . Introduction of rabbit N-acetylglucosaminyltransferase I (GnT I) into A. nidulans has resulted in the production of an in vitro active enzyme, but no evidence for in vivo GlcNAc transfer was found (23) . When human cDNA encoding GnT I was expressed in Trichoderma reesei, the incorporation of N-acetylglucoseamine into ␣-1,3-linked mannose of the core oligosaccharide Man 5 GlcNac 2 was demonstrated by 1 H nuclear magnetic resonance analysis, but the efficiency of this incorporation was not analyzed (29) . In contrast to yeast species, hyperglycosylation is not a typical feature of filamentous fungi, which most often synthesize small highmannose-type N-and O-glycans (2) . So far, no typical mammalian-like complex-type glycans have been found or generated in filamentous fungi (33) . Some of the glycans found resemble mammalian high-mannose glycans [Man (6) (7) (8) (9) GlcNAc 2 ]. In addition, typical "fungal-type" glycans that are structurally different from the mammalian glycans have been identified on different Aspergillus glycoproteins [Man (5) (6) (7) (8) (9) (10) (11) (12) GlcNAc 2 ] (1, 29, 44, 45) .
Moreover, growth conditions have been found to influence the glycan modification of some proteins, possibly by modulating the expression of enzymes involved in the fungal glycosylation pathway (12) .
In order to approach a solution for this important drawback in the possibility of using fungal heterologous glycoproteins for therapeutic applications (21, 28, 30) , we used an approach similar to that described for Pichia pastoris and systematically engineered the glycosylation pathways of two Aspergillus species. Here, we report the introduction of heterologous fusion proteins, such as mannosidases and glycosyltransferases, as well as the deletion of a gene (algC) coding for an enzyme involved in an early step of the fungal glycosylation pathway.
MATERIALS AND METHODS
Strains. The A. nidulans and A. niger strains used throughout this work are listed in Table 1 and Table 2 , respectively. The strain T2 carries an expression plasmid with a reporter protein and argB. This expression plasmid allows the purification of the reporter protein (the C-terminal six-His-tagged K3 domain of human plasminogen, as described in reference 6, and expressed from the A. nidulans gpdA promoter) and and will allow analysis of the glycosylation of the reporter protein in the future. E. coli strain JM 109 was used for routine plasmid propagation.
Cloning of pEKgnopat. From plasmid pAN52-1 (38), the ATG of the A. nidulans gpd promoter, as well as the NcoI site, was deleted by PCR using primers pAN52-SalF (5Ј-CGCAGACCGGGAACACAAGC-3Ј) and pAN52-BamR (5Ј-TAACGT TAAGTGGATCCAAGCTGATGTCTGC-3Ј). The resulting PCR fragment was cloned as a SalI-BamHI fragment into the SalI/BamHI-cut pAN52-1 vector. The NotI site of the vector pAN52-1 was deleted by partial digestion with NotI, filling in of the protruding ends, and subsequent ligation. Cloning sites consisting of NcoI, SwaI, AscI, and SbfI sites, as well as a PacI site, were introduced by cloning the annealed oligonucleotides Not Pac F New (5Ј-GATCCGCGGCCGCATTTAAAT GGCGCGCCCCTGCAGGTTAATTAAG-3Ј) and Not Pac R New(5Ј-GATCCT TAATTAACCTGCAGGGGCGCGCCATTTAAATGCGGCCGCG-3Ј) as BamHI fragments into the unique BamHI site of pAN52-1. Additionally, AsiSI, FseI, and PmeI restriction sites were introduced by cloning the annealed oligonucleotides pAN52 Marker F (5Ј-TATGGCGATCGCGGCCGGCCGTTTAAACCA-3Ј) and pAN52 Marker R (5Ј-TATGGTTTAAACGGCCGGCCGCGATCGCCA-3Ј) as NdeI fragments into the unique NdeI site of the vector, yielding the expression vector pEKgnopat.
Cloning of the A. niger mnnJ leader sequence. The putative MnnJ protein sequence was identified by a similarity search against the A. niger sequence database (Integrated Genomics, Chicago, IL) using S. cerevisiae Mnn10p (accession number YDR245W) as a query sequence. Using the mnnJ sequence information from the similarity search, the mnnJ leader sequence was amplified in a 5Ј rapid amplification of cDNA ends experiment with the specific primer RT MNN10 (5Ј-CTTCTCCCAGCTCTCGCGCCATTCG-3Ј) and cloned into pGEMT-easy for sequencing. The final leader sequence was amplified from the pGEMT-easy plasmid using the forward primer An-MNN10-5 (5ЈGCGGCCGC CACCATGCTATTCCTCTTCCGTCGTTTCGAGCTG-3Ј), creating a NotI restriction site (underlined), and the reverse primer An-MNN10-3 (5Ј-GGCGCG CCCCCATCGTTCCACATAATTCTTCTTGTTCCA-3Ј), creating an AscI site (underlined). The NotI-AscI fragments were used in subsequent cloning steps.
Cloning of ␣-1,2-mannosidase genes into pEKgnopat. The ␣-1,2-mannosidase catalytic domain-leader fusions were cloned into the NotI-PacI-digested pEKgnopat as NotI-PacI fragments. In the subsequent cloning step, the A. niger leader sequence was cloned as NotI-AscI fragments into the NotI-AscI-digested vector.
Cloning of GlcNAc-transferase I genes into pEKgnopat. The GlcNAc-transferase I catalytic domain-leader fusions NA15 and coNA15 were obtained as a gift from GlycoFi, Inc., in vectors pPB104 and pPB104-CO. coNA15 is a codonoptimized sequence for expression in P. pastoris. To achieve this, the human codons have been changed to the optimal P. pastoris codons following the codon usage table available at http://www.kazusa.or.jp/codon/. The plasmids were constructed by fusion of sequences coding for amino acids 1 to 40 of ScMNN9 to sequences coding for amino acids 38 to 445 of HsGNTI (Table 3 ) using the nucleotide sequences GGGCGCGCC and GGAAGAGCA, respectively, as fusion linkers in the process, adding the three amino acids GlyArgAla. In the case of pPB104, this fusion was accomplished by using the AscI site created by the additional nucleotides, and in the case of pPB104, the complete gene fusion sequence was assembled using oligonucleotides and fusion PCR. Both fusions were then released by NotI-PacI digestion and cloned into the NotI-PacI-digested pEKgnopat. Additionally, A. niger leader sequences were introduced into the pEKgnopat-NA15 plasmid by removing the MNN9 (no. 15) leader with a NotI-AscI digestion and cloning the A. niger leader as NotI-AscI fragments into the vector.
algC knockout constructs. The putative algC protein sequence was identified by a similarity search using S. cerevisiae Alg3p (accession number YBL082C) as a query against the A. nidulans sequence database at Broad Institute (http://www .broad.mit.edu) and the A. niger sequence database (Integrated Genomics, Chicago, IL). Additional 3Ј and 5Ј sequence information on the algC gene of A. niger was obtained by probing with the algC fragment a minilibrary based on restriction site analysis of A. niger strain 888. A colony lift and subsequent hybridization experiment with the algC PCR product as a probe revealed two clones that yielded additional 3Ј sequence information. algC was knocked out by a DNA fragment obtained by chimeric PCR. 3Ј and 5Ј fragments of the algC gene were amplified from chromosomal A. niger DNA with the primer pairs alg3 F (5Ј-G TCACGGTCAACGTCCTCCCTCT-3Ј) plus alg3_5primeR (5Ј-CACAACCAC CAGCGTGATCAAGTAGAG-3Ј) and alg3_3primeF (5Ј-GTTGCGATTAAG ATGACACTGTTGCTG-3Ј) plus alg3_3prime_R_new (5Ј-GGAGGTGAATT AGCTTGAGCGGAATA-3Ј). An hph fragment with algC overhangs was amplified from the vector pAN7 (38) using primers HmB_chimericF (5Ј-CTCTA CTTGATCACGCTGGTGGTTGTGTACACAGGCTCAAATCAATAAGAAG 
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ASPERGILLUS N-GLYCAN MODIFICATION 1077 AACG-3Ј) and HmB_chimericR (5Ј-CAGCAACAGTGTCATCTTAATCGCAA CTAGATGTGGAGTGGGCGCTTACAC-3Ј) and a long-run PCR kit (MBI Fermentas). The three fragments were purified via gel excision and assembled in a subsequent PCR, in which the overhangs of the hph fragment functioned as a primer. Amplification of the chimeric PCR product was performed with the primers alg3 F (5Ј-GTCACGGTCAACGTCCTCCCTCT-3Ј) and alg3_3prime_R_new (5Ј-GGAGGTGAATTAGCTTGAGCGGAATA-3Ј). Fifteen microliters of the PCR product was used directly for transformation.
To knock out the algC gene in A. nidulans, a recombinant DNA fragment was constructed via chimeric PCR. 5Ј and 3Ј fragments of the algC gene were amplified from chromosomal A. nidulans DNA with the primer pairs ANalgC5Ј_fwd (5Ј-GC TGTTGGAGGCTCTGGATAGAAA-3Ј) plus ANalgC5Ј_rev (5Ј-TGCCATTGTA GTTGATGAAGAAGAAGA-3Ј) and ANalgC3Ј_fwd (5Ј-GGACAACGTACATG CAACAGGTCA-3Ј) plus ANalgC3Ј_rev (5Ј-CCCGCGCAATTCCTTCTTTAG-3Ј). An argB fragment with algC overhangs was amplified from the vector pFB39 (43) using the primers chimeric-argB_fwd (5Ј-CTCTTCTTCTTCATCAACTAC AATGGCATATTTCGCGGTTTTTTGGGGTAGT-3Ј) and chimeric-argB_rev (5Ј-TGACCTGTTGCATGTACGTTGTCCTAGCCATTGCGAAACCTCA GAAG-3Ј) and a long-run PCR kit (Roche). The three fragments were purified and assembled in a subsequent PCR, in which the overhangs of the argB fragment functioned as primers, and amplification of the chimeric nested PCR was performed with the primers ANalgCnested_fwd (5Ј-GTGTATGGAAACGAG ACGATCATCTTC-3Ј) and ANalgCnested_rev (5Ј-GCAGCAGATATTCCAT TCAACCAAAG-3Ј) in one PCR; 15 l of the PCR product was used directly for transformation.
Aspergillus transformation. Transformation protocols basically followed the procedures published by Tilburn and colleagues (42) . Transformants were selected according to the selection marker used (Tables 1 and 2 ). The transformants were then checked by PCR and/or dot blot hybridization, as well as by Southern blot analysis. Replacement of A. nidulans algC by the marker gene was verified by PCR, using primers ANalgC5Ј_fwd (5Ј-GCTGTTGGAGGCTCTGG ATAGAAA-3Ј) and ANalgC3Ј_rev (5Ј-GGACAACGTACATGCAACAGGTC A-3Ј), which anneal to algC 5Ј and algC 3Ј sequences not present on the knockout construct, giving rise to a larger PCR product (4,881 bp) than an intact algC gene (2,923 bp).
Replacement of A. niger algC by the marker gene used a similar strategy, employing the algC 5Јprimers alg3_KO_PCR_F (5Ј-CGCCGCATCTACATCC CCG-3Ј) and alg3_KO_gpdA_R (5Ј-TTGGGACGATGCAAGATATAAACGA A-3Ј), which anneal to the gpdA promoter of the selection marker on the knockout construct. Additionally, the absence of algC coding sequence was verified by PCR with specific primers and by Southern analysis using an algC open reading frame fragment of either A. nidulans or A. niger.
Culture conditions. Strains were grown for 20 h at 37°C on 250 ml LB medium containing supplements according to the auxotrophy markers of the strain and ammonium tartrate (10 mM) as an additional nitrogen source. The mycelium was harvested by filtration, washed with ϳ500 ml of tap water, and ground to fine powder under liquid nitrogen, and the powder was subsequently lyophilized. The lyophilized biomass was used in glycan digestion and subsequent mass spectrometry (MS) analysis to determine the whole-cell glycosylation.
Glucoamylase production. Strains were grown on Aspergillus complete medium containing supplements according to the auxotrophy markers of the strain and ammonium tartrate (10 mM) as an additional nitrogen source for 50 h at 200 rpm and 37°C. The mycelium was harvested by filtration and washed with sterile water. Subsequently, the mycelium was transferred to fresh expression medium (70 g/liter trisodium citrate dihydrate, 20 ml/liter Aspergillus salt solution, and 10 g/liter maltodextrin, plus the respective supplements and ammonium tartrate [10 mM] as a nitrogen source) and cultivated for about 52 h at 200 rpm and 30°C. The culture supernatant (containing glucoamylase) was harvested and stored at Ϫ80°C. Glucoamylase was purified from the culture supernatant by size exclusion chromatography (PD-10 columns; Amersham Biosciences), using Tris, pH 8.0, according to the manufacturer's manual. The eluate was concentrated via ultrafiltration (Vivaspin 20-ml concentrator; 5,000 MWCO PES; VivaScience) and further purified via strong basic anion-exchange chromatography (Vivapure Q Mini H; VivaScience), using 25 mM Tris, pH 8.0, for equilibration and 1 M NaCl-25 mM Tris, pH 8.0 for elution. The purified protein was lyophilized.
Total cellular protein extraction and release of N-linked glycan. Total cellular protein was extracted by dissolving 50 mg of lyophilized and ground cell pellet in 0.5 ml RCM buffer (8 M urea, 360 mM Tris, and 3.2 mM EDTA, pH 8.6) at room temperature. Cell debris was removed by centrifugation for 15 min at 2,500 rpm in a Beckmann Coulter Allegra 6 centrifuge. The protein content of the supernatant was determined by protein assay (Bio-Rad, Hercules, CA). The glycans were released and separated from the glycoproteins by a modification of previously reported methods (4, 35) . Briefly, 50 g of solubilized proteins of various samples were adsorbed onto a polyvinylidene difluoride membrane in a 96-well MultiScreen IP plate (Millipore, Bedford, MA). After the proteins were reduced and carboxymethylated and the membranes were blocked, the wells were washed three times with water. The proteins were deglycosylated by the addition of 22 l of 10 mM NH 4 HCO 3 , pH 8.3, containing 1 mU PNGase F (New England Biolabs). After 16 h at 37°C, the solution containing the glycans was removed to a clean 96-well plate by centrifugation and evaporated to dryness.
MS analysis. The molecular weights of the glycans were determined using a Voyager DE PRO linear matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometer (Applied Biosciences) as described previously (6) . All spectra were generated with the instrument in the positive ion mode. In this MALDI-TOF ion mode, it is possible that phosphorylated glycans could not be detected, and the influence of the expression of ␣-1,2-mannosidase on phosphorylated fungal glycans has not been studied here. All of the masses obtained in MS analysis are summarized in Table 4 . In vitro ␣-1,2-mannosidase digestion. T. reesei ␣-1,2-mannosidase (a gift from R. Contreras, Unit of Fundamental and Applied Molecular Biology, Department of Molecular Biology, Ghent University, Ghent, Belgium) digestions were performed as described previously (4) .
RNA isolation. Strains were grown overnight on minimal medium containing the appropriate supplements at 37°C and 180 rpm. The mycelium was harvested and frozen in liquid nitrogen. RNA was isolated using Trizol according to the manufacturer's instructions (Gibco BRL).
qRT-PCR. Quantitative reverse transcription-PCR (qRT-PCR) for gene expression was performed with Platinum Sybr green qPCR SuperMix-UDG (Invitrogen) and a SuperScript III Platinum Two-Step qRT-PCR kit with Sybr green (Invitrogen) and was carried out on an iCycler thermal cycler with a MyiQ single-color real-time PCR detection system (Bio-Rad). Reactions were run in duplicate, and a mean value of the two samples was calculated. The results were calculated as the relative amount of product adjusted for the level of internal control amplification (actin mRNA) obtained for the sample. The primers used for quantification of BC10 in A. nidulans and A. niger were BC10fwd (5Ј-ACT GCCGGATACTCTGGAATC-3Ј) and trpCrev (5Ј-GATTTCAGTAACGTTA AGTGGATCC-3Ј), those for CD28 in A. nidulans and A. niger were CD28fwd (5Ј-TCGCCGAAACGCTTAAGTAC-3Ј) and trpCrev, those for coNA15 in A. nidulans and A. niger were coNA15 F (5Ј-CAAAACACAATGTCACTTTCTC TTGTATCCTAC-3Ј) and trpCrev, and those for mnnJ-NA in A. nidulans and A. niger were GNT F (5Ј-CTTGTATCGTACCGCCTAAGAAAGAACC-3Ј) and trpCrev. For amplification of the A. niger actin gene (accession no. AAU11333), the primers actNigR (5Ј-TATCTGAGGGTGAGGATACCACG-3Ј) and actNigerF (5Ј-GACAATGGTTCGGGTATGTGC-3Ј) were used. For amplification of the A. nidulans actin gene (accession no. AN6542.3), the primers actin F (5Ј-GATCGGTATGGGTCAGAAGGA-3Ј) and actin R (5Ј-CGATGTTGCCG TACAGATCC-3Ј) were used.
Nucleotide sequence accession numbers. The mnnJ leader sequence has been deposited with NCBI under accession number DQ841153. The A. niger algC sequence has been deposited under accession no. DQ841152. The accession number for A. nidulans algC is AN0104.3.
RESULTS AND DISCUSSION
Expression of functional ␣-1,2-mannosidase fusion proteins results in trimming of terminal mannose residues to putative Man 5 GlcNAc 2 structures. ␣-1,2-Mannosidase hydrolyzes terminal 1,2-linked ␣-D-mannose residues in the oligomannose oligosaccharide Man 9 GlcNAc 2 in a calcium-dependent manner to produce Man 8 GlcNAc 2 in a first step and Man 5 GlcNAc 2 N-glycans on glycosylated proteins in a second step (19) . Generation of Man 5 GlcNAc 2 is one of the critical steps in obtaining complex glycoproteins because this substrate is the precursor for all subsequent downstream processing steps (11) . In an attempt to express functional ␣-1,2-mannosidase in Aspergillus, cDNAs coding for leader sequences from enzymes known to target the protein to the ER or Golgi apparatus from S. cerevisiae, P. pastoris, or A. niger were combined in the pEKgnopat Aspergillus expression vector (see Materials and Methods) with different catalytic domains derived from Caenorhabditis elegans, Drosophila melanogaster, Mus musculus, and T. reesei. Leader sequences from putative A. niger orthologues of S. cerevisiae Gls1p, Mns1p, Mnn10p, Mnn11p, and Anp1p were identified and cloned by similarity searches against an A. niger sequence database (data not shown). Among all putative A. niger leaders, only the Mnn10p orthologue was found to be functional in combination with heterologous catalytic domains (see below). The combinatorial fusion constructs were individually transformed into A. niger strain T2 and A. nidulans strain YR23.5 (in A. nidulans, only constructs BC10 and CD28 were transformed), and the integration events were verified by PCR and Southern blotting (results not shown). The copy numbers of constructs integrated into the genome varied from one copy to several copies in our Southern analysis, potentially influencing the expression levels of the integrated genes. We determined the expression levels in at least two single-copy strains of each transformation event in Aspergillus complete medium (36) by qRT-PCR. Expression levels were monitored by a combination of ␣-1,2-mannosidase-specific and trpC terminator-specific primers, and the transcript levels obtained were normalized to the A. nidulans or A. niger actin gene acnA (see Materials and Methods). Additionally, the actin-normalized expression levels of the transgenes were compared with the actin-normalized mRNA levels of the endogenous gpdA genes of A. niger or A. nidulans. In single-copy transformants, similar mRNA levels (with differences of less than 20%) were recorded (data not shown). Such strains were selected for further analysis, for which the cultures were processed as described in Materials and Methods, and whole-cell glycans were released by PNGase digestion and analyzed by MALDI-TOF analysis.
Structure assignments were based on the masses (summarized in Table 4 ) and sensitivity to ␣-1,2-mannosidase. However, we cannot rule out the possibility of other hexoses. For example, in A. niger N-linked glycans, the presence of galactose in a galactofuranose conformation has been established (44, 46) . In this work, we did not analyze for their appearance by digestion with alternative mannosidases, such as an ␣-1,2/3/6-mannosidase.
Therefore, the masses of N-linked glycans released by PNGase F digestion of proteins obtained by MALDI-TOF are referred to as hexoses. For example, in the figures, we refer to a GlcNAc 2 Hex 6 structure as Hex 6 .
The BC10 construct (a P. pastoris SEC12 leader fused to a C. elegans ␣-1,2-mannosidase lacking a transmembrane domain [ Table 3 ]) was the only one found to be functional in A. niger and resulted in a considerable shift of glycan composition from mainly Man 8 GlcNAc 2 (Fig. 1A, right) to strongly elevated amounts of Man 5 GlcNAc 2 (Fig. 1B, right) . All other constructs were not functional in modifying the N-glycan masses; one example is shown in Fig. 1C , right, for the CD28 fusion construct (an S. cerevisiae MNN10 leader fused to a D. melanogaster ␣-1,2-mannosidase lacking a transmembrane domain). Of these two fusion proteins, only the expression of BC10 resulted in a different glycosylation pattern at the level of whole-cell glycans in A. nidulans. Figure 1 , left, compares the glycan masses obtained by MALDI-TOF analysis for the A. nidulans recipient strain YR23.5 ( Fig. 1A) with the spectra obtained from the strain expressing the BC10 construct (Fig.  1B) and an example of a typical spectrum obtained from a strain carrying a nonfunctional fusion construct (CD28) (Fig.  1C) . The mass spectrum of BC10 clearly shows elevated masses consistent with Man 5 GlcNAc 2 structures. Ions appearing with low abundance between Hex6 and Hex7 that have masses similar to GlcNAcMan 5 GlcNAc 2 in Fig. 1A and B are probably a matrix artifact and not N-linked glycans. The glycan patterns of A. nidulans (Fig. 1D, left) and A. niger (Fig. 1D, right) , which were obtained after in vitro digestions using purified ␣-1,2-mannosidase on whole-cell extracts, show an almost complete reduction of any N-glycan other than Man 5 GlcNAc 2 , and this result shows that the in vivo functionality of the ␣-1,2-mannosidase fusion constructs is only partial.
In addition to whole-cell glycan analysis, the N-glycans of a prominent secreted A. niger protein were analyzed. Glucoamylase, an enzyme secreted under starch or maltodextrin induc-tion, was purified (see Materials and Methods) and analyzed for glycan composition. The glycan pattern of glucoamylase was comparable to that of the whole-cell glycans, with a shift from Man 8 GlcNAc 2 to high levels of Man 5 GlcNAc 2 (Fig. 2) .
Interestingly, only one construct (BC10) was shown to be functional in both Aspergillus species at the level of whole-cell glycans (A. nidulans and A. niger) and on secreted glucoamylase (A. niger). As in P. pastoris, the catalytic domain of C. elegans worked best in both Aspergillus species. In P. pastoris, when combined with the S. cerevisiae leaders MNS1 and MNN10, the catalytic domain of C. elegans produced predominantly Man 5 GlcNAc 2 on the Pichia reporter protein K3 (6) . A slightly lower rate, as estimated from MALDI-TOF analysis, was observed in A. niger. Other constructs shown to be func- tional in Pichia were not successful in Aspergillus. Even though previous studies established a correlation between certain domains and targeting events, there is currently no tool available that allows one to predict the behavior of a given targeting peptide across different hosts. Accordingly, we were not able to predict from comparison of the primary protein sequences of functional versus nonfunctional mannosidases which of the constructs tested would work in Aspergillus.
Human ␤-1,2-N-acetylglucosaminyltransferase I (GNT I) is functional in vivo. The transfer of N-acetyl-D-glucosamine to Man 5 GlcNAc 2 substrates generated by the previous Man 8 GlcNAc 2 -to-Man 5 GlcNAc 2 trimming step was investigated. The GNT I enzyme localizes to the luminal face of the Golgi apparatus, allowing the sequential processing of glycoproteins as they are shuttled through the secretory pathway. In one construct, the catalytic domain of human GNT I (abbreviated as NA) was fused to the MNN9 leader (abbreviated as 15) from S. cerevisiae to yield construct NA15. In a second construct, a fungal codon-optimized form (coNA; see Materials and Methods for details) was combined with the same MNN9 leader to yield construct coNA15. Yet another construct used a leader sequence from a putative A. niger gene with similarity to the S. cerevisiae MNN10 gene, designated mnnJ according to the Aspergillus nomenclature (for the mnnJ accession number and all construct details, see Materials and Methods and Table 3 ). Fusion of the mnnJ leader sequence with NA yielded mnnJ-NA, which was, like all the other fusion constructs, subsequently integrated into the same expression vector backbone. These expression vectors were stably introduced by transformation into A. nidulans and A. niger strains already carrying the BC10 ␣-1,2-mannosidase construct, which showed the highest in vivo activity. Integration events were verified by PCR and Southern analysis, and expression of the constructs was tested by qRT-PCR (see Materials and Methods).
Whole-cell N-glycan analysis of A. niger BC10-transformed strains revealed that expression of the fusion construct coNA15 (Table 3 ) resulted in efficient transformation of Man 5 GlcNAc 2 to GlcNAcMan 5 GlcNAc 2 N-glycans, as seen from mass analysis (Fig. 3, right) . It is intriguing that in the A. niger T2-BC10 recipient strain a considerable portion of highermannose N-glycans, such as Man 6 GlcNAc 2 , Man 7 GlcNAc 2 , and Man 8 GlcNAc 2 , still existed in parallel with a large amount of Man 5 GlcNAc 2 (Fig. 3A, right) . In the strain additionally expressing the GNT I enzyme (Fig. 3B, right) , these highermannose glycans were significantly reduced.
The N-glycans released from the purified A. niger glucoamylase were subsequently analyzed in strains T2-BC10-coNA15 und T2-BC10-mnnJ-NA. The glycan pattern of glucoamylase was comparable to that of the whole-cell glycans, with a shift from Man 5 GlcNAc 2 to GlcNAcMan 5 GlcNAc 2 (Fig. 4) . Whereas at the level of whole-cell glycans, the construct mnnJ-NA was not functional at all (Fig. 3C, right) , some GlcNAc transfer was detected on glucoamylase (Fig. 4C) .
On glucoamylase of A. niger strain T2-BC10-coNA15, predominantly masses corresponding to GlcNAcMan 5 GlcNAc 2 were found, but (Man 5 -Man 9 )GlcNAc 2 and a mass consistent with GlcNAcMan 6 GlcNAc 2 were also detected. It remains to be determined whether introduction of a GlcNAc transporter would shift the glycosylation of secreted protein in A. niger toward GlcNAcMan 5 GlcNAc 2 , as was reported for P. pastoris (6) .
Whole-cell glycan analysis of the transformed strains, along with the A. nidulans BC10 recipient strain (Fig. 3A, left) , was carried out by mass spectrometry following glycan digestions. Of all transformants tested, the strain carrying construct coNA15 showed a new peak corresponding to the mass of GlcNAcMan 5 GlcNAc 2 structures (Fig. 3B, left) . Interestingly, the construct mnnJ-NA showed some activity in A. nidulans (Fig. 3C, left) but no activity in A. niger.
MnnJ is the putative orthologue of S. cerevisiae Mnn10p, which functions in a complex with MNN9p in a subunit of the yeast Golgi apparatus mannosyltransferase complex, also containing Anp1p, Mnn11p, and Hoc1p, that mediates elongation of the polysaccharide mannan backbone (22) . Interestingly, the 
VOL. 74, 2008
ASPERGILLUS N-GLYCAN MODIFICATION 1081
MnnJ leader sequence was the only fungal leader with significant activity out of five putative proteins derived from the Golgi apparatus mannosyltransferase complex. One GNT I construct was shown to be particularly active in A. niger and to shift the equilibrium of the enzymatic reaction toward GlcNAcMan 5 GlcNAc 2 . Interestingly, in the strain expressing only ␣-1,2-mannosidase from the BC10 construct, a considerable number of Man 7 GlcNAc 2 and Man 8 GlcNAc 2 glycan structures still existed in parallel with the large amount of Man 5 GlcNAc 2 (Fig. 3A, right) , but in the strain additionally expressing the GNT I enzyme (Fig. 3B, right) , these highermannose structures were almost completely lost. These results suggest that removal of Man 5 GlcNAc 2 , produced by ␣-1,2-mannosidase, by GNT I, which uses Man 5 GlcNAc 2 as a substrate, shifts the substrate-product equilibrium for ␣-1,2-mannosidase, which in turn results in a more active ␣-1,2-mannosidase enzyme along the glycosylation line. Additionally or alternatively, removal of Man 5 GlcNAc 2 could also remove the substrate for alternative resident glycosyltransferases. Moreover, in a GNT I strain expressing a nonfunctional ␣-1,2-mannosidase fusion construct (e.g., T2-CD28), no GlcNAcMan 5 GlcNAc 2 was detected, and therefore, it seems that the endogenous A. niger ␣-1,2-mannosidase is not sufficient to provide enough substrate for a functional GNT I enzyme. As already seen with the ␣-1,2-mannosidase fusion construct BC10, the GNT I fusion construct already shown to be functional in Pichia pastoris also worked best in Aspergillus. In contrast to the ␣-1,2-mannosidase, which showed only partial activity in Aspergillus, the GNT I construct led almost exclusively to GlcNAcMan 5 GlcNAc 2 , as reported for P. pastoris (6) . Our results on whole-cell glycan structures also suggest that the ␣-1,2-mannosidase fusion construct BC10 is correctly localized in Aspergillus and that ␣-1,2-mannosidase trimming occurs in the ER and early Golgi apparatus and not through secreted ␣-1,2-mannosidase in the medium. This was of concern, since leakage of ␣-1,2-mannosidase into the medium was reported by other groups (5, 6) . Generation of Man 3 GlcNAc 2 structures by knockout of the algC gene. The formation of N-glycosidic linkages of glycoproteins involves the ordered assembly of the common Glc 3 Man 9 GlcNAc 2 core oligosaccharide on the lipid carrier dolichyl pyrophosphate. Whereas early mannosylation steps occur on the cytoplasmic side of the ER with GDP-Man as the donor, the final reactions from Man 5 GlcNAc 2 -PP-Dol to Man 9 GlcNAc 2 -PP-Dol on the luminal side use Dol-P-Man. The ALG3 gene encodes the Dol-P-Man:Man 5 GlcNAc 2 -PP-Dol mannosyltransferase, which converts Man 5 GlcNAc 2 -Dol-PP to Man 6 GlcNAc 2 -Dol-PP. Knockout of ALG3 in S. cerevisiae and P. pastoris leads to specific Man 5 GlcNAc 2 structures, which can be trimmed to Man 3 GlcNAc 2 by ␣-1,2-mannosidase (Fig. 5) . We have previously shown that the distinct ⌬alg3 Man 5 GlcNAc 2 can be trimmed by ␣-1,2-mannosidases to obtain paucimannose FIG. 4 . N-glycan analysis of purified A. niger glucoamylase from strain T2-BC10, which served as a recipient for the GNT I constructs (A) (shown in Fig. 2B and repeated here for clarity), compared to strains T2-BC10-coNA15 (B) and T2-BC10-mnnJ-NA (C). Using roughly 1 kb of the nucleotide sequence upstream and downstream of the algC open reading frame, we generated by hybrid PCR two sets of deletion constructs. One construct carried between the upstream and downstream sequences the auxotrophic marker gene argB (for A. nidulans), while the other harbored the dominant hygromycin resistance marker gene hygB (for A. niger). We then generated algC knockout strains (⌬algC) for both organisms. Morphologically, A. nidulans strains YR23.5 and YR23.5-⌬algC did not show any significant differences. The knockout strain did not show any growth defects on minimal or complete medium and sporulated as well as the recipient and other algC ϩ strains (not shown). Analysis of the whole-cell glycans of the A. nidulans strain YR23.5-⌬algC showed a shift of the whole-cell glycan pattern to lower-mannose-type glycosylation. Additional masses, such as Man 3 GlcNAc 2 and Man 4 GlcNAc 2 , previously not seen in the parental strain were observed (Fig. 6A) . Structures larger than GlcNAcMan 3 GlcNAc 2 could be the result of endogenous glycosyltransferase activity capping the free ␣-1,6-mannose arm. However, knockout of algC efficiently inhibited core oligosaccharide assembly in A. nidulans, confirming that indeed we had for the first time cloned and deleted an ALG3 homologue of a filamentous fungus. We then tested whole-cell glycans in the A. niger T2-⌬algC knockout strain. As in A. nidulans, the lack of AlgC activity led to a shift of the wholecell glycan pattern to lower-mannose-type glycosylation, like Man 3 GlcNAc 2 and Man 4 GlcNAc 2 (not shown). In vitro digestion of N-glycans released from the A. niger ⌬algC strain with purified ␣-1,2-mannosidase led to an almost complete trimming of the Man 4 GlcNAc 2 , Man 5 GlcNAc 2 , and Man 6 GlcNAc 2 structures to Man 3 GlcNAc 2 (Fig. 6C) . When N-glycans released from glucoamylase purified from this strain were analyzed (not shown), the mass spectra showed a peak composition similar to that seen for A. niger whole-cell glycans, i.e., a loss of higher masses and the appearance of masses corresponding to Man 3 GlcNAc 2 to Man 6 GlcNAc 2 (Fig. 6B) .
Knockout of algC (AN0104.4) in A. nidulans led to some Man 3 GlcNAc 2 , in addition to Man 4 GlcNAc 2 and Man 5 GlcNAc 2 , which was the dominant glycan, as well as Man 6 GlcNAc 2 . In A. niger, the knockout of algC also led to the generation of masses consistent with Man 3 GlcNAc 2 and Man 4 GlcNAc 2 , structures not present in the parent strain (compare Fig. 1 ). Similarly to A. nidulans, Man 5 GlcNAc 2 and Man 6 GlcNAc 2 were additional glycans, in this case dominated by Man 6 GlcNAc 2 . In vitro digestion of T2-⌬algC whole-cell glycans led almost exclusively to Man 3 GlcNAc 2 paucimannose glycans. Previously observed larger glycan masses recalcitrant to in vitro ␣-1,2-mannosidase treatment in a P. pastoris ⌬alg3 ⌬och1 strain (7) were not detected in A. niger. Such larger structures can be formed by endogenous glycosyltransferases, which may add hexoses to various glycan structures (such as the unusual ⌬algC glycan created here) in vivo. Digestion of N-linked glycans derived from the ⌬algC strain with purified ␣-1,2-mannosidase led to an almost complete trimming of the masses consistent with Man 4 GlcNAc 2 , Man 5 GlcNAc 2 , and Man 6 GlcNAc 2 structures to Man 3 GlcNAc 2 . Similar larger-size oligosaccharides were observed after the cloning and deletion of the ALG3 gene in the methylotrophic yeast P. pastoris. This finding implies the existence of endogenous glycosyltransferases capable of transferring sugars to the canonical alg3 Man 5 N-glycan (7) . Subsequent experiments, such as the analysis of lipid-linked oligosaccharides, should allow the elucidation of these novel structures and will in turn provide a deeper understanding of the substrate specificity of glycosyltransferases residing in the secretory pathway in Aspergillus.
In sum, the findings presented here suggest, as also previously demonstrated for the methylotrophic yeast P. pastoris (4) , that the deletion of algC can indeed provide a promising route in Aspergillus for the addition of one additional GlcNAc residue to produce GlcNAcMan 3 GlcNAc 2 , and hence, to drive further the production of humanized complex glycoproteins in filamentous fungi.
